 Insciences Organisation | Halozyme gets boost from injectable Herceptin FierceDrugDelivery Roche and Halozyme are also applying the technology to a formulation of Roche's cancer drug rituximab and testing it in trials for patients with certain forms of lymphoma and leukemia. The firm's delivery tech involves the use of a recombinant enzyme ... Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase ... |
